Ivacaftor
CAS 873054-44-5
Overview
Ivacaftor is a drug used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator gene, who account for 4–5% cases of cystic fibrosis
Anant Labs manufacture and furnish high quality Ivacaftor impurities for global markets. Our Ivacaftor EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
Cat. No.ANT-IVC-000
CAS873054-44-5
Mol. FormulaC24H28N2O3
Mol. Weight392.49 g/mol
IUPACN-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide
SMILESCC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C
InChIInChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)
InChI KeyPURKAOJPTOLRMP-UHFFFAOYSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamideIvacaftor873054-44-5VX-770Kalydecoivacaftorum1Y740ILL1ZCHEBI:66901DTXSID00236281ORKAMBI COMPONENT IVACAFTOR
